A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

Clinical trial NCT07640893 · RECRUITING

Trial details

NCT number: NCT07640893
Sponsor: Shanghai RAAS Blood Products Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Von Willebrand Disease (VWD)

Start date: 2025-11-26
Primary completion: 2027-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.